Á lódáil...

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer

ErbB2 is an important member of the ErbB family, which activates growth and proliferation signaling pathways. ErbB2 is often overexpressed in various malignancies, especially in breast cancer, and is a common target for anti-cancer drugs. Breast cancer is currently one of the leading mortality cause...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Oncotarget
Main Authors: Wolfson, Eya, Goldenberg, Maria, Solomon, Shira, Frishberg, Amit, Pinkas-Kramarski, Ronit
Formáid: Artigo
Teanga:Inglês
Foilsithe: Impact Journals LLC 2016
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5323158/
https://ncbi.nlm.nih.gov/pubmed/27542246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11323
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!